Basic fibroblast growth factor accelerates matrix degradation via a neuro-endocrine pathway in human adult articular chondrocytes

J Cell Physiol. 2008 May;215(2):452-63. doi: 10.1002/jcp.21317.

Abstract

Pain-related neuropeptides released from synovial fibroblasts, such as substance P, have been implicated in joint destruction. Substance P-induced inflammatory processes are mediated via signaling through a G-protein-coupled receptor, that is, neurokinin-1 tachykinin receptor (NK(1)-R). We determined the pathophysiological link between substance P and its receptor in human adult articular cartilage homeostasis. We further examined if catabolic growth factors such as basic fibroblast growth factor (bFGF or FGF-2) or IL-1beta accelerate matrix degradation via a neural pathway upregulation of substance P and NK(1)-R. We show here that substance P stimulates the production of cartilage-degrading enzymes, such as matrix metalloproteinase-13 (MMP-13), and suppresses proteoglycan deposition in human adult articular chondrocytes via NK(1)-R. Furthermore, we have demonstrated that substance P negates proteoglycan stimulation promoted by bone morphogenetic protein-7, suggesting the dual role of substance P as both a pro-catabolic and anti-anabolic mediator of cartilage homeostasis. We report that bFGF-mediated stimulation of substance P and its receptor NK(1)-R is, in part, through an IL-1beta-dependent pathway.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Retracted Publication

MeSH terms

  • Adult
  • Arthritis, Rheumatoid / metabolism
  • Cartilage, Articular / drug effects
  • Cartilage, Articular / metabolism*
  • Cells, Cultured
  • Chondrocytes / drug effects
  • Chondrocytes / metabolism*
  • Extracellular Matrix / drug effects
  • Extracellular Matrix / metabolism*
  • Fibroblast Growth Factor 2 / pharmacology*
  • Humans
  • Interleukin-1beta / pharmacology
  • Matrix Metalloproteinase 13 / metabolism
  • Matrix Metalloproteinases / metabolism
  • Metabolism / drug effects
  • Mitogen-Activated Protein Kinases / metabolism
  • NF-kappa B / metabolism
  • Neurosecretory Systems / metabolism*
  • Osteoarthritis / metabolism
  • Proteoglycans / antagonists & inhibitors
  • Proteoglycans / biosynthesis
  • Receptors, Neurokinin-1 / metabolism
  • Signal Transduction
  • Substance P / metabolism
  • Substance P / pharmacology
  • Synovial Fluid / metabolism
  • Time Factors
  • Up-Regulation
  • raf Kinases / metabolism

Substances

  • Interleukin-1beta
  • NF-kappa B
  • Proteoglycans
  • Receptors, Neurokinin-1
  • Fibroblast Growth Factor 2
  • Substance P
  • raf Kinases
  • Mitogen-Activated Protein Kinases
  • Matrix Metalloproteinase 13
  • Matrix Metalloproteinases